Hainan Beikang Pharmaceutical Technology

Hainan Beikang Pharmaceutical Technology is a pharmaceutical company based in Haikou, Hainan, China, that operates as a Marketing Authorization Holder (MAH) for chemical drugs. Established in 2021, the company focuses on the development and registration of generic pharmaceutical products, with a portfolio that includes diagnostic imaging agents and anti-inflammatory medications. Its lead programs include Gadoxetate Disodium Injection, a liver-specific contrast agent for magnetic resonance imaging (MRI), and Sulindac Tablets, a non-steroidal anti-inflammatory drug (NSAID). Hainan Beikang utilizes a virtual business model, outsourcing its manufacturing to contract manufacturing organizations (CMOs) such as Hainan Better Pharmaceutical and Sichuan Pacific Pharmaceutical. The company is headquartered in the Haikou National High-tech Industrial Development Zone, positioning itself within Hainan's growing biomedical industrial cluster.